Congratulations on Rovathin successful complete of custom-synthesis project for BeiGene
About BeiGene (Beijing), Co.,Ltd
BeiGene is a clinical-stage biopharma company focused on discovering and developing innovative, best-in-class, targeted and immuno-oncology drugs that address severe unmet medical needs in a variety of cancer indications.The company collaboration with Merck Serono, the drug discovery unit of Merck KGaA, for BGB-290,currently is in Phase 1 development.